z-logo
Premium
TACHYKININ RECEPTORS AND NON‐CHOLINERGIC BRONCHOCONSTRICTION IN THE ANAESTHETIZED GUINEA‐PIG
Author(s) -
Yuan Liqun,
Burcher Elizabeth,
Nail Bruce
Publication year - 1996
Publication title -
clinical and experimental pharmacology and physiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.752
H-Index - 103
eISSN - 1440-1681
pISSN - 0305-1870
DOI - 10.1111/j.1440-1681.1996.tb02582.x
Subject(s) - bronchoconstriction , phosphoramidon , tachykinin receptor , cholinergic , stimulation , chemistry , substance p , antagonist , endocrinology , medicine , neurokinin a , receptor antagonist , guinea pig , receptor , pharmacology , neuropeptide , biology , endothelin receptor , asthma
SUMMARY 1. Bronchoconstriction can be evoked by electrical stimulation of the vagus nerves in the presence of atropine. We have used novel, highly selective tachykinin receptor antagonists, together with a procedure for on‐line, breath‐by‐breath analysis of total lung resistance (R l , subtractor method) and dynamic lung compliance (C dyn ), to investigate the role of tachykinins in this response in anaesthetized, paralysed guinea‐pigs. 2. In the presence of 1 mg/kg phosphoramidon (a neutral endopeptidase inhibitor), CP 96345 (the non‐peptide NK 1 selective antagonist) at 200 nmol/kg had no effect on the increase in R l caused by vagal stimulation, but significantly inhibited the associated decrease in C dyn. 3. The NK 2 selective antagonist, MDL 29913 (1 μmol/kg), significantly antagonized the changes in both R l and C dyn. In the absence of phosphoramidon, MDL 29913 again significantly inhibited the changes in R l and C dyn , although CP 96345 no longer had any effect. 4. The non‐peptide NK 2 selective antagonist, SR 48968 (100 nmol/kg), also effectively inhibited the responses to vagal stimulation and was more potent than MDL 29913. 5. These results emphasize the importance of the NK 2 receptor system in mediating non‐cholinergic bronchoconstriction evoked by vagal stimulation in the guinea‐pig.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here